Skip to main
CCRN
CCRN logo

CCRN Stock Forecast & Price Target

CCRN Analyst Ratings

Based on 3 analyst ratings
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Bulls say

Cross Country Healthcare has demonstrated a stabilization in gross margins at 20.0%, consistent with the previous quarter and surpassing estimates, indicating operational resilience. Additionally, the pending acquisition by Aya Healthcare at $18.61 per share represents a substantial 67% premium over the stock's closing price prior to the announcement, reflecting strong market confidence in the company's value. Furthermore, the anticipated timeline for the transaction's completion shifts to the second half of 2025, allowing for strategic positioning amid evolving market conditions.

Bears say

Cross Country Healthcare reported a significant decline in Adjusted EBITDA, dropping 44% year-over-year to $8.6 million in Q1/25, despite exceeding internal estimates. The company also experienced a revenue decline of 23% year-over-year to $293.4 million, which fell short of both internal and consensus estimates, reflecting ongoing softer demand in the healthcare travel staffing sector. Following these results, the revenue forecast for 2025 was revised downward to $1.166 billion, representing a decrease of 13.3% year-over-year from prior projections.

CCRN has been analyzed by 3 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 100% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cross Country Healthcare (CCRN) Forecast

Analysts have given CCRN a Hold based on their latest research and market trends.

According to 3 analysts, CCRN has a Hold consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.91, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.91, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cross Country Healthcare (CCRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.